POST STEM CELL TRANSPLANT

Clinical trials for POST STEM CELL TRANSPLANT explained in plain language.

Never miss a new study

Get alerted when new POST STEM CELL TRANSPLANT trials appear

Sign up with your email to follow new studies for POST STEM CELL TRANSPLANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Double-Drug maintenance may extend remission in multiple myeloma

Disease control Recruiting now

This phase 2 trial tests whether a combination of two drugs—talquetamab and lenalidomide—can help prevent multiple myeloma from returning after a stem cell transplant. The study enrolls 20 adults with symptomatic multiple myeloma who have already undergone a transplant. Participa…

Matched conditions: POST STEM CELL TRANSPLANT

Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control

Last updated Jul 19, 2026 00:00 UTC

POST STEM CELL TRANSPLANT

Get alerted when new POST STEM CELL TRANSPLANT trials appear

Double-Drug maintenance may extend remission in multiple myeloma